Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Mark W. Ball, Michael Gorin, Gunes Guner, Phillip Martin Pierorazio, George Netto, Channing Paller, Hans J. Hammers, Luis A. Diaz, Mohamad E Allaf

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalClinical Genitourinary Cancer
StateAccepted/In press - Mar 7 2016


  • Biomarker
  • Cell-free DNA
  • Kidney cancer
  • Next-generation sequencing
  • Treatment response

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this